Skip to content

LSD: all studies

Page 274 of 282: studies 2,731 to 2,740 of 2,816, newest first. Back to the LSD overview

Research

The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.

Pharmacology, Biochemistry, and Behavior January 1981 T Yamamoto, S Ueki

Head-twitch induced by lysergic acid diethylamide, mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM) was significantly increased by medial raphe (m-R) lesions, but dorsal raphe (d-R) lesions did not produce any changes. Hallucinogen-induced head twitch was inhibited by methysergide and tended to be increased by PCPA. These results suggest that 5-HT receptors innervated with the ascending...

LDS-25 as a discriminative stimulus for response selection by pigeons.

Pharmacology, Biochemistry, and Behavior October 1980 Torbjörn U C Järbe

Pigeons (N=4) were trained to discriminate between the effects induced by intramuscular (IM) injections of d-LSD and saline using a discrete-trial discrimination paradigm (choice between left and right hand key) in a conventional operant box. The solutions were administered IM 15 min prior to the sessions. A FR 15 schedule was in operation to produce food. Which of the two keys was correct on a...

DPT as an Adjunct in Brief Psychotherapy with Cancer Patients

OMEGA - Journal of Death and Dying February 1, 1980 William A. Richards, John Rhead, Stanislav Grof et al. 20 citations

Thirty cancer patients suffering from psychological distress participated in a pilot project of individual psychotherapy that offered – over a four week period of time – approximately twelve hours of conventional verbal interaction and a single intensive drug-assisted therapy session that employed dipropyltryptamine (DPT), a short-acting psychedelic drug. The efficacy of the total therapeutic...

DOI: 10.2190/ngub-v4rm-t7dc-xth3 (opens in new tab) Psychedelic therapy Dpt therapy Drug-assisted therapy Psychedelic treatment +15

MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.

Psychopharmacology 1980 H E Shannon

3,4-Methylenedioxyamphetamine (MDA) and 2,5-dimethoxy-4-methylamphetamine (DOM) are amphetamine congeners that produce both amphetamine-like and LSD-like effects. To evaluate whether MDA and DOM should be classed with amphetamine, their capacity to produce amphetamine-like discriminative stimuli was assessed. Rats were trained to discriminate between saline and 1.0 mg/kg d-amphetamine in a two...

Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.

Psychopharmacology 1980 E B Nielsen, T H Lee, G Ellison

Rats injected with LSD or mescaline show the behavioral syndrome which has been previously reported following injections of hallucinogens in higher mammals: limb flicks and whole body shakes. Although these behaviors are not elicited by acute injections of amphetamine, they are present in rats which have been pretreated for 108 h with a slow-release amphetamine pellet, given a 12 h rest period,...

EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.

Pharmacology, Biochemistry, and Behavior January 1980 Matthew Fairchild, Donald J. Jenden, M R Mickey et al.

Three hallucinogens (d-lysergicacid diethylamide (LSD), mescaline, psilocybin) and two cannabinoid derivatives (tetrahydrocannabinol (THC), synhexyl) were tested for their long-term effects on the EEG of the cat. The drug-induced alterations in the EEG frequency spectrum were "drug-specific" in the sense that they would be statistically unlikely to occur during sleep-waking behavior. The two...

Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugs.

Pharmacology, Biochemistry, and Behavior November 1979 Heidrun Fink, R Morgenstern, Wolfgang Oelssner

The spontaneous locomotor activity of rats was investigated in an open-field test. Apomorphine and d,1-amphetamine caused a dose dependent increase of locomotor activity. LSD, mescaline, and DMT in low doses were ineffective, when given alone, but caused a strong potentiation of the hypermotility induced by apomorphine and d,1-amphetamine. Cyproheptadine antagonized the potentiating effect of...

A characteristic effect of hallucinogens on investigatory responding in rats.

Psychopharmacology September 1979 Mark A. Geyer, Roger K. Light, Gary J. Rose et al.

The disruption of the temporal distribution of investigatory responses by rats in a novel hole-board following lysergic acid diethylamide-25 (LSD), as described in a companion paper (Geyer and Light, 1979), was found to be a characteristic effect of a variety of hallucinogens. Similar effects were produced by indoleamine hallucinogens, such as LSD, N,N-dimethyltryptamine, and psilocin, and by...

Steam sterilisation of sandpits infected with toxocara eggs.

BMJ May 19, 1979 F. van Knapen, J.h. Franchimont, G M Otter 21 citations

The law was subsequently changed to make possession of the plant illegal.Thus unless the Act is amended to name the psilocybin mushroom possession is legal.Apparently increasing numbers of teenagers and others are harvesting and eating the mushrooms.2Doctors should therefore be aware of possible long-term side effects of such agents.One of these is the flashback phenomenon described by about 5%...

DOI: 10.1136/bmj.1.6174.1320 (opens in new tab) Full text (opens in new tab) Helminths Sterilization economics Toxocariasis

SHAPE CHANGE OF BLOOD PLATELETS—A MODEL FOR CEREBRAL 5‐HYDROXYTRYPTAMINE RECEPTORS?

British Journal of Pharmacology April 1, 1979 Martin Graf, A. Pletscher 45 citations

In blood platelets of rabbits isolated by a stractan gradient and incubated in a protein‐poor medium, tryptamine, 5‐hydroxytryptamine (5‐HT) and derivatives, quipazine and mescaline caused a shape change. This shape change was inhibited by low concentrations of methysergide. The most potent antagonists of the 5‐HT‐induced shape change included ergoline derivatives and neuroleptic drugs, which...